Target intelligence / Profile preview

Non-specific extracellular matrix components and ocular surface

Molecular classification
Extracellular matrix components, Glycosaminoglycans, Proteoglycans, Structural proteins
01

Overview

The 'Non-specific extracellular matrix components and ocular surface' refers to the structural and biochemical environment of the eye's outermost layers, primarily the cornea and conjunctiva. This matrix is composed of a variety of proteins, such as collagen and laminin, and glycosaminoglycans like hyaluronic acid, which together maintain tissue transparency and hydration (Source: Progress in Retinal and Eye Research). It serves as a critical scaffold for epithelial cells and a substrate for the tear film, ensuring a smooth optical surface and protection against pathogens (Source: StatPearls). In ocular surface diseases like dry eye, the degradation or insufficiency of these components leads to tear film instability and chronic inflammation (Source: Investigative Ophthalmology & Visual Science). Pharmacological management typically involves the use of ocular lubricants and artificial tears that physically supplement the ECM to restore lubrication and moisture (Source: Journal of Ocular Pharmacology and Therapeutics). Because this target represents a broad physiological system rather than a specific molecular entity, it is generally addressed through physical and mechanical mechanisms of action rather than high-affinity binding to a single receptor.

Other names
Ocular surface extracellular matrixCorneal and conjunctival ECMTear film-associated matrix components
02

Mechanism of action

Physical lubrication and hydration of the ocular surface, stabilization of the tear film, and replacement of deficient natural extracellular matrix components to reduce friction and inflammation (Source: StatPearls).

03

Biological functions

Structural supportHydrationCell adhesionLubricationBarrier functionTear film stabilization
04

Disease associations

Dry eye syndromeKeratoconjunctivitis siccaCorneal ulcerOcular surface diseaseSjögren's syndrome
05

Safety considerations

Transient blurred vision (Source: Mayo Clinic)Ocular irritation (Source: FDA)Hypersensitivity to preservatives like benzalkonium chloride (Source: Journal of Ocular Pharmacology and Therapeutics)Foreign body sensation
06

Interacting drugs

Sodium hyaluronate (Source: PubChem)

5 more in the full profile.

07

Biomarkers

Tear break-up time (TBUT) (Source: American Academy of Ophthalmology)Schirmer test (Source: StatPearls)Corneal fluorescein staining (Source: Mayo Clinic)Ocular Surface Disease Index (OSDI) (Source: Journal of Clinical Medicine)

Beyond the preview

Go deeper on Non-specific extracellular matrix components and ocular surface.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Non-specific extracellular matrix components and ocular surface.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call